MyAverix Finance
NS · Pharmaceuticals
Caplin Point Laboratories Ltd (CAPLIPOINT)
Pharmaceuticals & Biotechnology
Caplin Point Laboratories Ltd (CAPLIPOINT) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $189.27B, P/E ratio is 47.73, net margin is 39.9%, dividend yield is 0.16%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CAPLIPOINT
Caplin Point Laboratories Ltd (CAPLIPOINT) — FAQ
What is Caplin Point Laboratories Ltd's market cap?
Caplin Point Laboratories Ltd (CAPLIPOINT) has a reported market cap of $189.27B (data as of 2026-07-10).
What is CAPLIPOINT's P/E ratio?
The price-to-earnings (P/E) ratio for Caplin Point Laboratories Ltd (CAPLIPOINT) is 47.73 (data as of 2026-07-10).
Does Caplin Point Laboratories Ltd pay a dividend?
Caplin Point Laboratories Ltd (CAPLIPOINT) shows a reported dividend yield of 0.16%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).
What sector is Caplin Point Laboratories Ltd in?
Caplin Point Laboratories Ltd (CAPLIPOINT) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is CAPLIPOINT listed on?
CAPLIPOINT is listed on NS.
What is Caplin Point Laboratories Ltd's net margin?
Caplin Point Laboratories Ltd (CAPLIPOINT) reports a net margin of 39.9% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.